Search Results for: LXRX
by H.S. AyoubBioHealth Investor.com Biotechnology PROTALIX BIOTHERAPEU [PLX] +18.45% GENETIC TECH SPON [GENE] +13.83% NPS PHARM INC [NPSP] +6.34% VIACELL, INC. [VIAC] +6.13% DYAX CORP [DYAX] +4.66%...
Published:
Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2 diabetes.
Published:
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of scientists and the whims of the FDA. Poniard Pharmaceuticals (PARD) and...
Published:
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista...
Published:
Last Updated:
Hewlett Packard Enterprise, Equifax, New York REIT, and Lexicon Pharmaceuticals all posted new 52-week lows on Wednesday.
Published:
Last Updated:
Lexicon shares fell on Friday after the FDA voted to approve the firm’s type 1 diabetes treatment. Although the result from this committee was mixed, it seems to be a case of sell the news.
Published:
Last Updated:
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Published:
by H.S. AyoubBioHealth Investor.com Biotechnology DENDREON CORP [DNDN] +10.29% NORTHFIELD LABS IN [NFLD] +10.25% COMBINATORX [CRXX] +9.56% ONYX PHARM INC [ONXX] +8.70% SEQUENOM INC [SQNM] +8.08%...
Published:
Shares of Lexicon Pharmaceuticals saw a hand gain early on Friday after the company reported top-line results from its late-stage trial in type-1 diabetes.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated:
Equifax, New York REIT, Opko, and Lexicon Pharma all posted new 52-week lows Thursday.
Published:
Last Updated:
(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.(ADVNA) Advanta trades ex-split to reflect a 3-2 stock split.(AGU) Agrium said earnings will be at or above the upper...
Published:
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Published:
Lexicon Pharmaceuticals rallied Friday on late-stage results from a pivotal Phase 3 clinical trial of a type 1 diabetes treatment.
Published:
Last Updated:
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated: